Alivus Life Sciences informs about analyst meet

09 Jun 2025 Evaluate
Alivus Life Sciences has informed that pursuant to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, details of the meetings with Investor/Analyst which will be held on June 12, 2025 and attended by the representatives of the Company is enclosed.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

913.00 5.45 (0.60%)
02-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.35
Dr. Reddys Lab 1255.45
Cipla 1510.95
Zydus Lifesciences 916.50
Lupin 2105.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×